Abstract:The biological impact of NAD boosting on aging and cellular senescence is not completely understood. It appears that NAD is necessary for senescent cell function. Therefore, NAD boosting may increase senescence‐induced dysfunction. Combination of NAD boosters with senolytic therapy may be a promising approach to improve NAD‐targeted interventions, potentially benefiting age‐related diseases. However, no studies on this combination therapy have been reported yet. The geroscience hypothesis proposes that addressing the biology of aging could directly prevent the onset or mitigate the severity of multiple chronic diseases. Understanding the interplay between key aspects of the biological hallmarks of aging is essential in delivering the promises of the geroscience hypothesis. Notably, the nucleotide nicotinamide adenine dinucleotide (NAD) interfaces with several biological hallmarks of aging, including cellular senescence, and changes in NAD metabolism have been shown to be involved in the aging process. The relationship between NAD metabolism and cellular senescence appears to be complex. On the one hand, the accumulation of DNA damage and mitochondrial dysfunction induced by low NAD+ can promote the development of senescence. On the other hand, the low NAD+ state that occurs during aging may inhibit SASP development as this secretory phenotype and the development of cellular senescence are both highly metabolically demanding. However, to date, the impact of NAD+ metabolism on the progression of the cellular senescence phenotype has not been fully characterized. Therefore, to explore the implications of NAD metabolism and NAD replacement therapies, it is essential to consider their interactions with other hallmarks of aging, including cellular senescence. We propose that a comprehensive understanding of the interplay between NAD boosting strategies and senolytic agents is necessary to advance the field.

NAD metabolism: Role in senescence regulation and aging

NAD+ metabolism and its roles in cellular processes during ageing

Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process

Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan

Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases

NAD+ Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications

The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions

NAD+ homeostasis in health and disease

NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging

Vitamin B3, the Nicotinamide Adenine Dinucleotides and Aging

Implications of NAD+ boosters in translational medicine

Regulation of and challenges in targeting NAD + metabolism

The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

NAD+ metabolism, stemness, the immune response, and cancer

Regulatory Effects of NAD + Metabolic Pathways on Sirtuin Activity.

Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells

Nicotinamide, Nicotinamide Riboside and Nicotinic Acid—Emerging Roles in Replicative and Chronological Aging in Yeast

Evolving concepts in NAD+ metabolism

Implications of altered NAD metabolism in metabolic disorders

Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging